| Literature DB >> 35902606 |
Amandine Schmutz1, Nathaniel Spofford2, Walter Burghardt3, Geert De Meyer4.
Abstract
The increasing attention for the dog-owner relationship combined with advances in nutrition and veterinary care have made wellbeing a focal point for dog owners, veterinarians, and dog product and service providers. While canine wellbeing can be quantified by survey-based quality of life instruments like those used in human healthcare, there are currently few instruments available that can do this reliably and at scale. Here we report the development and initial validation of a canine quality of life instrument specifically designed to quantify wellbeing in the general dog population. The instrument is based on a simple 32-question survey and includes 5 daytime domains (energetic, mobile, relaxed, happy, sociable) and 3 mealtime domains (relaxed, interested and satisfied). It captures specific health-related aspects as well as more general wellbeing aspects and, in an initial sample of 2813 dogs, already provides useful insights on canine wellbeing. We believe that data collection at scale with this instrument will help bring optimal wellbeing to the dogs we care for.Entities:
Mesh:
Year: 2022 PMID: 35902606 PMCID: PMC9334304 DOI: 10.1038/s41598-022-16315-y
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.996
Characteristics and basic signalment information for the 3 studies performed. Summaries for continuous variables are given as mean (standard deviation).
| Study name | Employee | Citizen science | Hospital client |
|---|---|---|---|
| Geography | United Kingdom and United States | United States | United States |
| Items tested | 94 | 98 | 36 |
| Sample size | – | 3929 | 49,000 |
| Respondents | 310 | 868 | 1635 |
| Response rate (%) | – | 22.1 | 3.3 |
| Repeat respondents | – | – | 421 |
| Dog breeds | – | 105 | 120 |
| Toy | – | 14.1 | 17.2 |
| Small | – | 25.9 | 27.4 |
| Medium | – | 21.9 | 21.7 |
| Large | – | 35.0 | 30.8 |
| Giant | – | 3.2 | 3.1 |
| Dog age in years | – | 7.3 (3.6) | 6.5 (4.1) |
| Youth | – | 44.5 | 52.0 |
| Midlife | – | 23.0 | 28.4 |
| Senior | – | 32.6 | 19.6 |
| Dog sex (% female–% male) | – | 50.4–49.6 | 47.0–53.0 |
| Respondents with medical record | – | 854 | 1635 |
| Number of visits in medical record | – | 19.8 (14.6) | 17.2 (14.1) |
| Time between survey and last visit (years) | – | 0.27 (0.39) | 0.21 (0.18) |
Figure 1Instrument factor loadings and domain mapping obtained for instrument development (1996 surveys) and for an independent validation (817 surveys). Item and domain prefixes day and meal refer to daytime and mealtime, respectively.
Figure 2Domain score distribution for all surveyed dogs. Boxes delineate the 25th and 75th percentiles and show the median position in between. Whiskers indicate the range of all data excluding outliers and extreme values. The fraction of outliers and extreme values is represented explicitly as the dots representing these are overplotted.
Effect of body condition score (BCS), sex, size and life stage on domain score.
| Day.Energetic | Day.Relaxed | Day.Sociable | Day.Mobile | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Crude effect | Scaled effect | p value | Crude effect | Scaled effect | p value | Crude effect | Scaled effect | p value | Crude effect | Scaled effect | p value | |
| < 0.001 | 0.947 | 0.761 | < 0.001 | |||||||||
| Normal | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||
| Overweight | − 0.54 | − 0.44 | 0.00 | − 0.01 | − 0.01 | − 0.02 | − 0.13 | − 0.40 | ||||
| 0.339 | 0.052 | 0.788 | 0.496 | |||||||||
| Female | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||
| Male | 0.12 | 0.10 | 0.09 | 0.17 | − 0.04 | − 0.08 | 0.00 | 0.00 | ||||
| 0.005 | 0.269 | 0.002 | 0.150 | |||||||||
| Toy | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||
| Small | 0.03 | 0.03 | 0.17 | 0.31 | 0.06 | 0.13 | 0.04 | 0.11 | ||||
| Medium | − 0.01 | 0.00 | 0.11 | 0.20 | 0.03 | 0.05 | 0.02 | 0.05 | ||||
| Large | 0.20 | 0.16 | 0.10 | 0.19 | 0.12 | 0.25 | 0.06 | 0.19 | ||||
| Giant | 0.02 | 0.01 | 0.19 | 0.36 | 0.11 | 0.24 | − 0.07 | − 0.20 | ||||
| < 0.001 | 0.072 | < 0.001 | < 0.001 | |||||||||
| Youth | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||
| Midlife | − 0.67 | − 0.55 | − 0.10 | − 0.19 | − 0.10 | − 0.22 | − 0.16 | − 0.49 | ||||
| Senior | − 1.32 | − 1.09 | − 0.06 | − 0.12 | − 0.28 | − 0.60 | − 0.67 | − 2.07 | ||||
Effects are expressed versus a reference category either on the 1 to 7 domain score scale (crude effect) or approximately scaled to the domain score population standard deviation (scaled effect).
Effect of Osteoarthritis, gastro-intestinal (GI) disease, cardiac disease, dental disease, and skin disease on domain scores.
| Day.Energetic | Day.Relaxed | Day.Sociable | Day.Mobile | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Crude effect | Scaled effect | p value | Crude effect | Scaled effect | p value | Crude effect | Scaled effect | p value | Crude effect | Scaled effect | p value | |
| < 0.001 | 0.163 | < 0.001 | < 0.001 | |||||||||
| Absent | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||
| Present | − 0.93 | − 0.77 | − 0.06 | − 0.12 | − 0.19 | − 0.41 | − 0.86 | − 2.66 | ||||
| 0.760 | 0.099 | 0.530 | 0.653 | |||||||||
| Absent | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||
| Present | − 0.03 | − 0.02 | − 0.13 | − 0.24 | − 0.01 | − 0.02 | 0.03 | 0.09 | ||||
| < 0.001 | 0.888 | < 0.001 | < 0.001 | |||||||||
| Absent | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||
| Present | − 0.98 | − 0.81 | 0.00 | 0.00 | − 0.16 | − 0.34 | − 0.28 | − 0.87 | ||||
| < 0.001 | < 0.001 | < 0.001 | < 0.001 | |||||||||
| Absent | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||
| Present | − 0.75 | − 0.62 | − 0.23 | − 0.44 | − 0.19 | − 0.41 | − 0.21 | − 0.64 | ||||
| < 0.001 | 0.190 | 0.543 | < 0.001 | |||||||||
| Absent | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||
| Present | − 0.38 | − 0.31 | 0.10 | 0.19 | − 0.04 | − 0.09 | − 0.10 | − 0.31 | ||||
Effects are expressed versus a reference category either on the 1 to 7 domain score scale (crude effect) or approximately scaled to the domain score population standard deviation (scaled effect). The present category included 301 dogs for osteoarthritis, 86 for GI disease, 214 for cardiac disease, 608 for dental disease, and 335 for skin disease.